Lo JF - Search Results

1

Tid1 negatively regulates the migratory potential of cancer cells by inhibiting the production of interleukin-8.

Kim SW, Hayashi M, Lo JF, Fearns C, Xiang R, Lazennec G, Yang Y, Lee JD. Kim SW, et al. Among authors: lo jf. Cancer Res. 2005 Oct 1;65(19):8784-91. doi: 10.1158/0008-5472.CAN-04-4422. Cancer Res. 2005. PMID: 16204048

2

BMK1 mediates growth factor-induced cell proliferation through direct cellular activation of serum and glucocorticoid-inducible kinase.

Hayashi M, Tapping RI, Chao TH, Lo JF, King CC, Yang Y, Lee JD. Hayashi M, et al. Among authors: lo jf. J Biol Chem. 2001 Mar 23;276(12):8631-4. doi: 10.1074/jbc.C000838200. Epub 2001 Jan 31. J Biol Chem. 2001. PMID: 11254654 Free article.

3

ADP-ribosylation factor 4 small GTPase mediates epidermal growth factor receptor-dependent phospholipase D2 activation.

Kim SW, Hayashi M, Lo JF, Yang Y, Yoo JS, Lee JD. Kim SW, et al. Among authors: lo jf. J Biol Chem. 2003 Jan 24;278(4):2661-8. doi: 10.1074/jbc.M205819200. Epub 2002 Nov 21. J Biol Chem. 2003. PMID: 12446727 Free article.

4

Investigating the cellular BMK1/ERK5 signaling pathway.

Tapping RI, Yutaka K, Chao TH, Hayashi M, Lo JF, Kim SW, Lee JD. Tapping RI, et al. Among authors: lo jf. Methods Mol Biol. 2004;250:89-96. doi: 10.1385/1-59259-671-1:89. Methods Mol Biol. 2004. PMID: 14755081 No abstract available.

5

Tid1, a cochaperone of the heat shock 70 protein and the mammalian counterpart of the Drosophila tumor suppressor l(2)tid, is critical for early embryonic development and cell survival.

Lo JF, Hayashi M, Woo-Kim S, Tian B, Huang JF, Fearns C, Takayama S, Zapata JM, Yang Y, Lee JD. Lo JF, et al. Mol Cell Biol. 2004 Mar;24(6):2226-36. doi: 10.1128/MCB.24.6.2226-2236.2004. Mol Cell Biol. 2004. PMID: 14993262 Free PMC article.

6

Tid1, the human homologue of a Drosophila tumor suppressor, reduces the malignant activity of ErbB-2 in carcinoma cells.

Kim SW, Chao TH, Xiang R, Lo JF, Campbell MJ, Fearns C, Lee JD. Kim SW, et al. Among authors: lo jf. Cancer Res. 2004 Nov 1;64(21):7732-9. doi: 10.1158/0008-5472.CAN-04-1323. Cancer Res. 2004. PMID: 15520177

7

Tid1 is required for T cell transition from double-negative 3 to double-positive stages.

Lo JF, Zhou H, Fearns C, Reisfeld RA, Yang Y, Lee JD. Lo JF, et al. J Immunol. 2005 May 15;174(10):6105-12. doi: 10.4049/jimmunol.174.10.6105. J Immunol. 2005. PMID: 15879105

8

DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor.

Zhou H, Luo Y, Lo JF, Kaplan CD, Mizutani M, Mizutani N, Lee JD, Primus FJ, Becker JC, Xiang R, Reisfeld RA. Zhou H, et al. Among authors: lo jf. Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):10846-51. doi: 10.1073/pnas.0502208102. Epub 2005 Jul 22. Proc Natl Acad Sci U S A. 2005. PMID: 16040807 Free PMC article.

9

Nuclear factor kappaB (NF-kappaB) activation primes cells to a pro-inflammatory polarized response to a Toll-like receptor 7 (TLR7) agonist.

Lee J, Hayashi M, Lo JF, Fearns C, Chu WM, Luo Y, Xiang R, Chuang TH. Lee J, et al. Among authors: lo jf. Biochem J. 2009 Jun 26;421(2):301-10. doi: 10.1042/BJ20090013. Biochem J. 2009. PMID: 19426145 Free PMC article.

10

Activation of rabbit TLR9 by different CpG-ODN optimized for mouse and human TLR9.

Liu J, Xu C, Liu YL, Matsuo H, Hsieh RP, Lo JF, Tseng PH, Yuan CJ, Luo Y, Xiang R, Chuang TH. Liu J, et al. Among authors: lo jf. Comp Immunol Microbiol Infect Dis. 2012 Sep;35(5):443-51. doi: 10.1016/j.cimid.2012.03.008. Epub 2012 May 2. Comp Immunol Microbiol Infect Dis. 2012. PMID: 22560893

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters